Positroscint Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.40 Cr
as on 16-11-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.48 Cr
as on 16-11-2024
- Revenue -21.73%
(FY 2023)
- Profit 161.74%
(FY 2023)
- Ebitda 49.75%
(FY 2023)
- Net Worth 1690.10%
(FY 2023)
- Total Assets -30.51%
(FY 2023)
About Positroscint
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹24.48 Cr.
Sunil Aggarwal, Shashi Aggarwal, and Gaurav Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24200PB2020PTC050698
- Company No.
050698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Positroscint?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashi Aggarwal  | Director | 24-Sep-2021 | Current |
| Gaurav Aggarwal | Director | 29-Jan-2020 | Current |
| Sunil Aggarwal | Director | 30-Sep-2021 | Current |
Financial Performance of Positroscint.
Positroscint Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.73% decrease. The company also saw a substantial improvement in profitability, with a 161.74% increase in profit. The company's net worth Soared by an impressive increase of 1690.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Positroscint?
Unlock access to Positroscint's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biomex Instruments Private LimitedActive 34 years 5 daysSunil Aggarwal, Shashi Aggarwal and 1 more are mutual person
Cheema Medical Complex Private LimitedActive 2 years 7 monthsSunil Aggarwal, Shashi Aggarwal and 1 more are mutual person
Dynamic Diagnostics Private LimitedActive 5 years 5 monthsSunil Aggarwal and Gaurav Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Feb 2023 | ₹24.48 Cr | Open |
How Many Employees Work at Positroscint?
Unlock and access historical data on people associated with Positroscint, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Positroscint, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Positroscint's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
